Sweden · Delayed Price · Currency is SEK Acuvi AB Earnings Call Transcripts
Fiscal Year 2026
-
Q1 sales remained stable at SEK 51.2 million, but EBITDA fell due to non-recurring cost increases and accelerated depreciation. High-margin PiezoMotor nearly doubled sales, and new U.S. defense orders offset a lost med tech deal. Cash flow and APAC growth are key focus areas.
Fiscal Year 2025
-
Net sales rose 25% in Q4 and 18% for the year, driven by deeper customer relationships and a shift to in-house sales. Adjusted EBITDA was positive, but non-recurring costs weighed on reported results. 2026 targets include 10% top-line growth and higher EBITDA, with focus on high-margin products and new markets.
-
A precision technology firm is shifting to direct sales in key markets to boost margins and customer engagement, while maintaining distributor partnerships in Asia. Financial targets remain unchanged, the company is now cash flow positive, and M&A is a strategic priority.